References
- Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164–76
- D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468–75
- Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151–7
- Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004; 350: 1646–54
- Forns X, Gines A, Gines P, Arroyo V. Management of ascites and renal failure in cirrhosis. Semin Liver Dis 1994; 14: 82–96
- Spahr L, Villeneuve JP, Tran HK, Pomier-Layrargues G. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites. Hepatology 2001; 33: 28–31
- Laffi G, La Villa G, Pinzani M, Foschi M, Carloni V, Casini Raggi V, et al. Refractory ascites: definition, pathogenesis and treatment. Ann Ital Med Int 1993; 8: 38–46
- Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003; 38: S69–S89
- Buonamico P, Sabba C, Garcia-Tsao G, Berardi E, Antonica G, Ferraioli G, et al. Octreotide blunts post-prandial splanchnic hyperemia in cirrhotic patients: a double-blind randomized echo-Doppler study. Hepatology 1995; 21: 134–9
- Sieber C, Gnadinger M, del Rozo E, Shaw S, Weidmann P. Effect of a new somatostatin analogue SMS 201–995 (sandostatin) on the renin-aldosterone axis. Clin Endocrinol 1988; 28: 25–32
- Sabat M, Guarner C, Soriano G, Bulbena O, Novella MT, Ortiz J, et al. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Dig Dis Sci 1998; 43: 2184–9
- Kurokawa K, Aponte G, Fujibayashi S, Yamada T. Somatostatin-like immunoreactivity in the glomerulus of rat kidney. Kidney Int 1983; 24: 754–7
- Izumi Y, Honda M, Hartano M. Effect of somatostatin on plasma renin activity. Endocrinologica Jpn 1979; 26: 389–94
- Aguilera G, Parker DS, Gatt KJ. Characterization of somatostatin receptors in rat adrenal glomerulosa zone. Endocrinology 1982; 111: 1376–82
- Aguilera G, Parker DS, Gatt KJ. Somatostatin modulates effects of angiotensin II in adrenal glomerulosa zone. Nature 1982; 292: 262–3
- Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia-Villarreal L, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995; 21: 986–94
- Bernardi M, Trevisani R, Capelli M, Bugiardini G, Gasbarrini G. Study of renal function, renin-aldosterone axis and plasma electrolytes during diuretic treatment of patients with cirrhosis of the liver and ascites. Ital J Gastroenterol 1982; 14: 199–204